Distinct cancers rely on unique regulatory circuits: for instance, HCC frequently engages SIRT1–p62 or PCAF–microtubule pathways, whereas breast cancer emphasizes p300/CREBBP-driven stabilization of transcription factors (e.g., HOXB13, RB1CC1). This evidence concerns the gene KAT2B and hepatocellular carcinoma.